AMRN: Amarin Corporation plc Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMRN: Amarin Corporation plc

AMRN 13.70

+0.3%

9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (37)	5/9/2012 10:43:07 PM
From: Miljenko Zuanic	Read Replies (2) of 49

Interesting development in the omega-3 business front. basf.com Today BASF reported acquisition of the Equateq, The Scottish company that suppose to be “domestic” Amarins supplier of the API. They are the only one who hold DMF for EPA-E (beside Nisshin, Japan), and also they have some interesting technology that BASF was interested. Just to clarify, AMRN has zero right on technology to produce high purity EPA-E (API). Not clear to me is BASF going after API market or Dietary Supplement. PR does not mention Amarin or high purity EPA-E at all. Also, based on yesterday CC, CEO of AMRN sounded “NONFAMILIAR” with this acquisition. Responding to few API questions he was talking about forth (domestic) supplier. PS: Chemport (Korea, third Amarin supplier) ) also have DMF on ~90% pure EPA-E, but that is not sufficient in purity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next